A comprehensive study reveals how the ‘Alzheimer's gene’ (APOE ε4) affects the nature of the disease. It is not simply that those with the gene variant tend to be more impaired (in terms of both memory loss and brain damage) than those without. Different parts of the brain (and thus different functions) tend to be differentially affected, depending on whether the individual is a carrier of the gene or not. Carriers displayed significantly greater impairment on tests of memory retention, while noncarriers were more impaired on tests of working memory, executive control, and lexical access. Consistent with this, carriers showed greater atrophy in the mediotemporal lobe, and noncarriers greater atrophy in the frontoparietal area. The findings have implications both for diagnosis and treatment.
Alzheimer's expressed differently in carriers and noncarriers of the Alzheimer’s gene
Reference
Wolk, D. A., & Dickerson, B. C. (2010). Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer’s disease. Proceedings of the National Academy of Sciences, 107(22), 10256-10261. Retrieved from http://www.pnas.org/content/107/22/10256.abstract
Related News
Losing muscle mass early sign of Alzheimer’s
Previous research has found that unexplained weight loss is an early sign of Alzheimer's. Now a study involving 140 older adults (60+), of whom half had early-stage Alzheimer's disease, has revealed that it is not the overall weight or fat levels that are important, but the loss of lean mass (weight of an individual's bones, muscles and organs without body fat). This directly correlated with reductions in the volume of the whole brain and of white matter only, along with declines in cognitive performance.
Low vitamin D levels related to lower cognitive function in MS sufferers
A study involving 236 persons with multiple sclerosis has found that only 7% of those with secondary-progressive MS showed sufficient vitamin D in their blood, compared to 18.3% of patients with the less severe relapsing-remitting type, and that higher levels of vitamin D3 and its byproducts were associated with better scores on cognitive tests (especially reasoning and planning), and less brain atrophy and fewer brain lesions. Lower-than-normal vitamin D status is known to be associated with a higher risk of developing MS
Personality may influence brain shrinkage in aging
An imaging study involving 79 volunteers aged 44 to 88 has found lower volumes of gray matter and faster rates of decline in the frontal and medial temporal lobes of those who ranked high in neuroticism traits, compared with those who ranked high in conscientious traits. These are brain regions particularly affected by aging. The idea that this might occur derived from the well-established effects of chronic stress on the brain. This is the first study to investigate whether the rate and extent of cognitive decline with age is influenced by personality variables.
Specific hippocampal atrophy early sign of MCI & Alzheimer's
A three-year study involving 169 people with mild cognitive impairment has found that those who later developed Alzheimer's disease showed 10-30% greater atrophy in two specific locations within the hippocampus, the cornu ammonis (CA1) and the subiculum.
Frequent episodes of jet lag without sufficient recovery time may reduce cognitive function
A study of 20 flight attendants suggests that people who undergo repeated, frequent episodes of jet lag without sufficient recovery time between trips may develop actual tissue changes in the brain in an area that's involved in spatial orientation and related aspects of cognitive function. The extent to which this is due to sleep deprivation rather than time shifts per se is unknown. These findings may also be relevant to shift workers, medical trainees and others who work long hours.
Diabetes duration and severity associated with brain atrophy
Submitted by Fiona McPherson
on
A study involving 614 patients with type 2 diabetes (mean age 62) has found that longer duration of diabetes was associated with more brain volume loss, particularly in the gray matter. Roughly, for every 10 years of diabetes, the brain was similar to that of a non-diabetic person who was two years older.
However, the study did not confirm any association of diabetes characteristics with small vessel ischemic disease.
http://www.eurekalert.org/pub_releases/2014-04/rson-dda042214.php
Genes implicated in late-onset Alzheimer's disease
Submitted by Fiona McPherson
on
11 new genetic susceptibility factors for Alzheimer’s identified
The largest international study ever conducted on Alzheimer's disease (I-GAP) has identified 11 new genetic regions that increase the risk of late-onset Alzheimer’s, plus 13 other genes yet to be validated. Genetic data came from 74,076 patients and controls from 15 countries.
Eleven genes for Alzheimer's disease have previously been identified.
Mental imagery training improves multiple sclerosis patients' cognition
Training in a mental imagery technique has been found to help multiple sclerosis patients in two memory domains often affected by the disease: autobiographical memory and episodic future thinking.
Different kinds of physical activity improve brain volume & cut Alzheimer's risk
Data from 876 patients (average age 78) in the 30-year Cardiovascular Health Study show that virtually any type of aerobic physical activity can improve brain volume and reduce Alzheimer's risk.
Cognitive tests for MCI & Alzheimer's
Memory tests predict brain atrophy and Alzheimer's disease
Data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), involving 230 cognitively normal individuals and 394 individuals with diagnosed with MCI on the basis of one episodic test, has found that performance on two tests markedly improved the identification of those whose MCI was more serious.
MCI can be a step on the road to Alzheimer's, but it can also be a reversible condition, and it’s obviously helpful to be able to distinguish the two.